X4 Pharmaceuticals, Inc.
XFOR
$3.57
$0.071.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 230.37% | 168.80% | 147.89% | -9.47% | -62.70% |
| Total Receivables | 9.76% | -5.20% | -66.49% | 49.67% | 118.38% |
| Inventory | 73.56% | 50.11% | 59.00% | 66.87% | 281.47% |
| Prepaid Expenses | -44.35% | -56.88% | -54.83% | 5.00% | -0.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 200.04% | 152.86% | 133.19% | -7.11% | -58.42% |
|
|
|||||
| Total Current Assets | 200.04% | 152.86% | 133.19% | -7.11% | -58.42% |
| Net Property, Plant & Equipment | -73.62% | -71.47% | -67.13% | -62.33% | -48.94% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 36.11% | -7.64% | -7.50% | -7.36% | -7.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27.28% | -76.63% | -66.73% | -16.72% | 31.36% |
| Total Assets | 140.63% | 107.89% | 98.34% | -8.20% | -50.07% |
|
|
|||||
| Total Accounts Payable | -48.97% | -54.36% | -33.93% | -41.09% | -3.47% |
| Total Accrued Expenses | 8.11% | 35.24% | -19.13% | -15.52% | -33.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -66.01% | -43.75% | -20.54% | -1.80% | 16.72% |
| Total Finance Division Other Current Liabilities | 11.67% | 6.43% | -- | -- | -- |
| Total Other Current Liabilities | 11.67% | 6.43% | -- | -- | -- |
| Total Current Liabilities | -15.42% | -8.16% | -21.66% | -19.66% | -20.78% |
|
|
|||||
| Total Current Liabilities | -15.42% | -8.16% | -21.66% | -19.66% | -20.78% |
| Long-Term Debt | 1.21% | 1.18% | 1.15% | 1.11% | 1.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -94.59% | -59.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -9.79% | -65.37% | -85.44% | -81.53% | -83.88% |
| Total Liabilities | -3.55% | -4.89% | -16.19% | -14.01% | -12.88% |
|
|
|||||
| Common Stock & APIC | 44.34% | 45.57% | 45.26% | 18.14% | 2.15% |
| Retained Earnings | -16.67% | -19.36% | -15.37% | -20.00% | -23.24% |
| Treasury Stock & Other | 10.87% | 4.69% | 10.66% | -3.51% | 13.21% |
| Total Common Equity | 3,814.73% | 634.18% | 741.08% | 3.35% | -95.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3,814.73% | 634.18% | 741.08% | 3.35% | -95.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3,814.73% | 634.18% | 741.08% | 3.35% | -95.80% |
|
|
|||||